Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1980 1
1981 1
1982 1
1983 2
1984 3
1985 3
1986 4
1987 6
1988 14
1989 21
1990 10
1991 12
1992 19
1993 8
1994 21
1995 11
1996 8
1997 30
1998 22
1999 31
2000 46
2001 48
2002 82
2003 115
2004 138
2005 194
2006 220
2007 216
2008 263
2009 267
2010 278
2011 350
2012 310
2013 295
2014 318
2015 292
2016 285
2017 327
2018 315
2019 296
2020 319
2021 332
2022 290
2023 267
2024 101

Text availability

Article attribute

Article type

Publication date

Search Results

5,530 results

Results by year

Filters applied: . Clear all
Page 1
Resistance of Candida to azoles and echinocandins worldwide.
Pristov KE, Ghannoum MA. Pristov KE, et al. Clin Microbiol Infect. 2019 Jul;25(7):792-798. doi: 10.1016/j.cmi.2019.03.028. Epub 2019 Apr 6. Clin Microbiol Infect. 2019. PMID: 30965100 Free article. Review.
These infections can be superficial, affecting the skin or mucous membrane, or invasive, which can be life-threatening. Azoles and echinocandins are antifungal drugs used globally to treat Candida infections. ...IMPLICATIONS: Increased resistance to azoles and echinocan …
These infections can be superficial, affecting the skin or mucous membrane, or invasive, which can be life-threatening. Azoles and echino …
Echinocandins in antifungal pharmacotherapy.
Patil A, Majumdar S. Patil A, et al. J Pharm Pharmacol. 2017 Dec;69(12):1635-1660. doi: 10.1111/jphp.12780. Epub 2017 Jul 26. J Pharm Pharmacol. 2017. PMID: 28744860 Review.
Moreover, echinocandin regimen has been shown to be more cost-effective and economical. Hence, the echinocandins have found favour in the management of invasive systemic fungal infections. ...
Moreover, echinocandin regimen has been shown to be more cost-effective and economical. Hence, the echinocandins have found fa …
The echinocandins.
Cappelletty D, Eiselstein-McKitrick K. Cappelletty D, et al. Pharmacotherapy. 2007 Mar;27(3):369-88. doi: 10.1592/phco.27.3.369. Pharmacotherapy. 2007. PMID: 17316149 Review.
Three echinocandins have been approved by the United States Food and Drug Administration: caspofungin, micafungin, and anidulafungin. ...After speciation of the organism, continued therapy with an echinocandin can and should be reevaluated. The echinocandins …
Three echinocandins have been approved by the United States Food and Drug Administration: caspofungin, micafungin, and anidulafungin. …
Echinocandins in Ocular Therapeutics.
Patil A, Majumdar S. Patil A, et al. J Ocul Pharmacol Ther. 2017 Jun;33(5):340-352. doi: 10.1089/jop.2016.0186. Epub 2017 Feb 24. J Ocul Pharmacol Ther. 2017. PMID: 28437176 Review.
Even though their use through the different routes of administration has shown favorable outcomes, challenges such as poor ocular penetration, low bioavailability, ocular toxicity, and systemic side effects limit their utility. Hence, in search of alternative strategies, the e …
Even though their use through the different routes of administration has shown favorable outcomes, challenges such as poor ocular penetratio …
[Echinocandins: Applied pharmacology].
Azanza Perea JR. Azanza Perea JR. Rev Iberoam Micol. 2016 Jul-Sep;33(3):140-4. doi: 10.1016/j.riam.2016.02.004. Epub 2016 Jul 6. Rev Iberoam Micol. 2016. PMID: 27395024 Review. Spanish.
The echinocandins share pharmacodynamic properties, although there are some interesting differences in their pharmacokinetic behaviour in the clinical practice. ...They are highly bound to plasma proteins, thus it is recommended to administer a loading dose for anidulafung …
The echinocandins share pharmacodynamic properties, although there are some interesting differences in their pharmacokinetic behaviou …
Echinocandins in children.
Hoffman JA, Walsh TJ. Hoffman JA, et al. Pediatr Infect Dis J. 2011 Jun;30(6):508-9. doi: 10.1097/INF.0b013e31821b95e2. Pediatr Infect Dis J. 2011. PMID: 21587028 Review. No abstract available.
Echinocandins: The Expanding Antifungal Armamentarium.
Aguilar-Zapata D, Petraitiene R, Petraitis V. Aguilar-Zapata D, et al. Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S604-11. doi: 10.1093/cid/civ814. Clin Infect Dis. 2015. PMID: 26567277 Review.
The echinocandins are large lipopeptide molecules that, since their discovery approximately 41 years ago, have emerged as important additions to the expanding armamentarium against invasive fungal diseases. Echinocandins exert in vitro and in vivo fungicidal action …
The echinocandins are large lipopeptide molecules that, since their discovery approximately 41 years ago, have emerged as important a …
Echinocandins: production and applications.
Emri T, Majoros L, Tóth V, Pócsi I. Emri T, et al. Appl Microbiol Biotechnol. 2013 Apr;97(8):3267-84. doi: 10.1007/s00253-013-4761-9. Epub 2013 Mar 6. Appl Microbiol Biotechnol. 2013. PMID: 23463246 Review.
The first echinocandin-type antimycotic (echinocandin B) was discovered in the 1970s. ...In this review, we show the structural diversity of natural echinocandins, and we summarize the emerging data on their mode of action, biosynthesis and industrial product …
The first echinocandin-type antimycotic (echinocandin B) was discovered in the 1970s. ...In this review, we show the structura …
Echinocandins for the nursery: an update.
Manzoni P, Benjamin DK Jr, Franco C, Rizzollo S, Stronati M, Watt K, Cohen-Wolkowiez M, Jacqz-Aigrain E. Manzoni P, et al. Curr Drug Metab. 2013 Feb;14(2):203-7. Curr Drug Metab. 2013. PMID: 22935065 Review.
Recently, new therapeutic alternatives have drawn the neonatologists' attention. Echinocandins are a new class of antifungal drugs with characteristics that might better meet the needs of this particular population of patients. ...Further studies properly designed for neon …
Recently, new therapeutic alternatives have drawn the neonatologists' attention. Echinocandins are a new class of antifungal drugs wi …
Echinocandins--new antifungal agents.
Stan CD, Tuchiluş C, Stan CI. Stan CD, et al. Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):528-36. Rev Med Chir Soc Med Nat Iasi. 2014. PMID: 25076727
All echinocandins inhibit beta-1,3-glucan-synthase, an essential component of the fungal cell wall. ...The available echinocandins lack in vitro activity against Cryptococcus neoformans. ...
All echinocandins inhibit beta-1,3-glucan-synthase, an essential component of the fungal cell wall. ...The available echinocandins …
5,530 results